HIF1 alpha mediated angiogenesis and mammalian Target of Rapamycin (mTOR) activation: implications for treatment of tuberous sclerosis

Andrew Tee, S.C. Land, E. A. Dunlop, M. Davies, M. H. Shen, J. R. Sampson

Research output: Contribution to journal › Book/Film/Article review › peer-review

Cite this

@article{d74f9d8ae70f4886b7bc1200e0b23c03,

title = "HIF1 alpha mediated angiogenesis and mammalian Target of Rapamycin (mTOR) activation: implications for treatment of tuberous sclerosis",

author = "Andrew Tee and S.C. Land and Dunlop, \{E. A.\} and M. Davies and Shen, \{M. H.\} and Sampson, \{J. R.\}",

year = "2007",

language = "English",

volume = "44",

pages = "S17 ",

journal = "Journal of Medical Genetics",

issn = "0022-2593",

publisher = "BMJ Publishing Group",

}

TY - JOUR

T1 - HIF1 alpha mediated angiogenesis and mammalian Target of Rapamycin (mTOR) activation: implications for treatment of tuberous sclerosis

AU - Tee, Andrew

AU - Land, S.C.

AU - Dunlop, E. A.

AU - Davies, M.

AU - Shen, M. H.

AU - Sampson, J. R.

PY - 2007

Y1 - 2007

M3 - Book/Film/Article review

SN - 0022-2593

VL - 44

SP - S17

JO - Journal of Medical Genetics

JF - Journal of Medical Genetics

ER -